Bumrungrad International Hospital
| タイ | トルコ | オーストリア | |
| 脳腫瘍の化学療法 | から $5,500 / 187,000฿ | から $1,000 / 34,000฿ | から $12,000 / 408,000฿ |
Bookimedは脳腫瘍の化学療法価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。到着時にクリニックで脳腫瘍の化学療法代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。脳腫瘍の化学療法で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。脳腫瘍の化学療法の旅路でお一人になることはありません。
Top-rated hospitals for brain tumor treatment in Thailand include Bumrungrad International Hospital and Bangkok International Hospital. These Joint Commission International (JCI) accredited facilities utilize Gamma Knife radiosurgery and robotic-assisted technology. Specialized neuro-oncology centers in Bangkok provide advanced chemotherapy and precise brain mapping for international patients.
Bookimed Expert Insight: High-volume centers like Bumrungrad serve over 1 million patients annually. This massive scale often leads to lower costs for advanced infusions. Patients often find chemotherapy prices are significantly lower than in Singapore. Choosing a high-volume hospital ensures access to authentic, specialized oncology medications.
Patient Consensus: Patients value the multidisciplinary approach in Bangkok for aggressive tumors like glioblastoma. Many recommend confirming the specific surgeon's caseload for your tumor type before arrival.
Thailand provides a wide range of chemotherapy drugs for brain tumors, including the gold-standard Temozolomide (TMZ) for glioblastomas. Specialized centers like Bumrungrad International Hospital offer advanced regimens including nitrosoureas, Lomustine, and targeted therapies like Bevacizumab (Avastin), maintaining 95% alignment with international oncology protocols.
Bookimed Expert Insight: While drug availability is high, savvy patients prioritize clinics with Global Healthcare Accreditation (GHA). Bumrungrad International Hospital serves over 500,000 international patients annually, proving their logistics chain is robust. This high volume typically prevents common regional supply crunches for specialized drugs like Temozolomide.
Patient Consensus: Patients report that while protocols mirror US standards, early tumor genetic testing is crucial. This step ensures the selected drug regimen effectively matches the specific tumor subtype available in Thailand.
Brain tumor chemotherapy in Thailand typically lasts 6 to 12 months, utilizing specialized protocols like Temozolomide (TMZ) or PCV regimens. Treatment cycles often involve an initial 5 to 6-week induction phase followed by maintenance periods of 5 days on medication and 23 days off.
Bookimed Expert Insight: Data from major Bangkok centers shows a trend toward condensed 9-month protocols compared to 12-month Western standards. This efficiency often stems from aggressive induction phases using both oral TMZ and localized implants like Gliadel wafers. Patients should confirm their full cycle count in writing to ensure maintenance phases align with international oncology guidelines.
Patient Consensus: Many find oral chemotherapy more convenient for international travel as it requires fewer hospital visits than infusions. Patients suggest packing anti-nausea medications as the local climate can sometimes intensify common treatment side effects.
Innovative alternatives to chemotherapy for brain tumors in Thailand include immunotherapy, targeted molecular therapy, and high-precision radiation. Hospitals like Bumrungrad International Hospital utilize advanced genomic sequencing to identify specific mutations, enabling personalized treatments such as IDH inhibitors or BRAF inhibitors that often cause fewer side effects.
Bookimed Expert Insight: While chemotherapy is standard, Thailand’s top JCI-accredited centers now lead with molecular profiling. Bumrungrad International Hospital serves patients from 190 countries by combining AI-driven diagnostics with neuro-oncology. This approach helps doctors choose targeted drugs that work where traditional chemotherapy might fail.
Patient Consensus: Patients emphasize the value of seeking second opinions at major Bangkok hubs for access to CyberKnife. Success often depends on detailed genetic testing to unlock targeted treatment options beyond standard protocols.
Thai private hospitals strictly follow international brain tumour protocols like NCCN and ESMO. Major centres maintain Joint Commission International (JCI) accreditation for global safety standards. Specialists use multidisciplinary tumour boards and the Stupp Protocol. This synchronises surgery, radiation, and chemotherapy for patients.
Bookimed Expert Insight: Leading Bangkok clinics function as massive medical hubs. Bumrungrad International alone treats 1,000,000 patients annually. This high volume means their 1,300 doctors have handled virtually every tumour type. Their use of electronic health records makes sharing files with Australian GPs seamless.
Patient Consensus: Patients in Thailand recommend choosing major university or private centres for integrated oncology care. They value getting English medical records. They also suggest confirming telehealth options for follow-up before returning home.
Leading Thai oncology centres provide chemotherapy and targeted therapy for brain tumours, including Temozolomide, Bevacizumab, and Carmustine wafers. Specialists at JCI-accredited facilities like Bumrungrad International Hospital use these medications to penetrate the blood-brain barrier. Treatment typically costs from $5,500 to $9,500. This saves up to 75% compared to Australian averages.
Bookimed Expert Insight: Basic chemotherapy is widely available. However, facilities like Bumrungrad treat over 1,000,000 patients annually using multidisciplinary tumour boards. Specialists review genetic markers before prescribing targeted drugs like Everolimus. This is a significant advantage for rare tumour types.
Patient Consensus: Patients find that Thai centres provide clear written plans before travel. These plans include dosing and side effects. They suggest confirming if infusions are day-clinic or inpatient stays. This helps better manage local accommodation in Bangkok.
Specialist multidisciplinary teams at JCI-accredited hospitals in Bangkok manage brain tumour care. Neurosurgeons and neuro-oncologists lead these teams. They coordinate surgery, chemotherapy, and radiation through dedicated units like the Horizon Regional Cancer Center at Bumrungrad International Hospital.
Bookimed Expert Insight: Major Bangkok centres like Bumrungrad International Hospital treat over 500,000 international patients annually. This high volume means their 1,300+ doctors are experienced in managing complex cross-border handovers. This is vital for patients returning to Australian GPs for ongoing monitoring.
Patient Consensus: Dealing with one hospital team in Thailand makes treatment feel less fragmented. Patients should ask for a written plan in English. A named lead doctor can then keep their Australian specialist informed.
Patients can fly home to Australia between chemotherapy cycles with formal medical clearance. This clearance must come from both their oncologist and the airline. Brain tumours present specific neurological risks at high altitudes. These risks include cerebral oedema and lowered seizure thresholds. Travel typically occurs outside the immune-compromised nadir period.
Bookimed Expert Insight: JCI-accredited centres like Bumrungrad International Hospital in Bangkok serve over 500,000 international patients annually. Their oncology departments are experienced in complex care logistics. They provide the documentation required by Australian airlines for patients to meet fitness-to-fly criteria.
Patient Consensus: Travellers recommend checking blood counts before flights and booking flexible tickets. Many found that bringing a detailed English medication list made the transition much smoother.
Bumrungrad International Hospital and Bangkok International Hospital are the leading recommendations for brain tumour care in Thailand. These hospitals specialise in multidisciplinary oncology and neurosurgery. They use technologies like the EDGE radiosurgery system and intraoperative MRI to treat complex tumours. These tools help surgeons preserve vital brain function.
Bookimed Expert Insight: Bumrungrad International Hospital is a standout for Australians. It manages over 1,000,000 patients annually with 50% coming from overseas. This massive volume means their teams see rare brain tumour cases frequently. Having 70 departments on one campus allows patients to move easily through treatment. They can access diagnosis, chemotherapy, and neuro-rehabilitation without changing facilities.
Patient Consensus: Patients in Thailand recommend choosing major Bangkok hospitals. This allows surgery and chemotherapy to happen at one site. They advise confirming telehealth follow-up options for Australia. Patients also suggest requesting detailed estimates to keep track of any care plan changes.